Tag: biosimilars billing
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Buy Cheap Generic Azithromycin Online - 2025 Guide
Oct, 9 2025
Hydration Plans to Protect Kidneys from Nephrotoxic Medications
Nov, 21 2025
Smart Prescription Savings: Fintech Solutions vs Coupon Apps
Aug, 9 2025
Tinnitus and Ringing in the Ears from Medications: What to Know
Dec, 21 2025
Asian Generic Pharmaceutical Markets: Analyzing India, China, and Emerging Hubs
Apr, 27 2026